Keim Mark Lowell's Form 4 filing
Molina Healthcare, Inc. (MOH) · filed Feb 14, 2024
- Accession no.
- 0001179929-24-000037
- Filed
- Feb 14, 2024
- Trade date
- Feb 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $5.80M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Keim Mark LowellCIK 0001690677 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | SSaleDisposed | −1,264 | $388.61F1 | −$491,203.04 | 50,267 | Direct | |
| Feb 12, 2024 | Common Stock | SSaleDisposed | −4,251 | $387.94F2 | −$1,649,132.94 | 46,016 | Direct | |
| Feb 12, 2024 | Common Stock | SSaleDisposed | −4,351 | $387.00F3 | −$1,683,837 | 41,665 | Direct | |
| Feb 12, 2024 | Common Stock | SSaleDisposed | −1,203 | $385.80F4 | −$464,117.4 | 40,462 | Direct | |
| Feb 12, 2024 | Common Stock | SSaleDisposed | −1,815 | $384.58F5 | −$698,012.7 | 38,647 | Direct | |
| Feb 12, 2024 | Common Stock | SSaleDisposed | −2,116 | $383.82F6 | −$812,163.12 | 36,531 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.